معرفی
Elie Nader is a Senior Lecturer in Exercise Physiology at Université Claude Bernard Lyon 1, affiliated with the Vascular Biology and Red Blood Cell Team (VBRBC). His research focuses on erythrocyte senescence and vascular function in pathological contexts such as sickle cell disease and hereditary spherocytosis, as well as physiological responses to altitude and exercise.
His research interests include:
- Exercise physiology in hematological disorders
- Red blood cell pathophysiology
- Vascular dysfunction in sickle cell disease
- Effects of acute and chronic altitude exposure
- Oxidative stress and nitric oxide bioavailability
The recent trends in his publications (2020–2024) highlight a strong focus on sickle cell disease, particularly on vascular complications, exercise implications, and red blood cell dysfunction. His work often involves collaboration across multiple disciplines and institutions, reflecting a translational and integrative approach.
He collaborates nationally with institutions such as HP2 Laboratory (Grenoble), UMR_S1134 (Pointe à Pitre), and medical departments at Hospices Civils de Lyon, and internationally with the University of Colorado Anschutz Medical Campus (USA) and the German Sport University of Cologne (Germany). Industrial collaborations include Erytech Pharma (France) and Hartis Pharma (Switzerland).
Elie Nader has presented at 12 national and international conferences and has published 21 papers as of 2021. His work is frequently published in high-impact journals such as Frontiers in Immunology, American Journal of Hematology, and Acta Physiologica.
He leads research within the VBRBC team, working closely with colleagues like Philippe Connes, and his projects often integrate clinical, physiological, and molecular approaches to understand and improve outcomes in patients with blood disorders.
